analyst
EX
NASDAQ · EXEL
Exelixis, Inc.
Healthcare · Biotechnology
$72.31
Up+$0.44 (+0.61%)
Updated Nov 5, 2026, 1:26 AM
SID Score
7.6/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 11.1B
- P/E ratio
- 16.39
- Dividend yield
- 0.00%
- 52-week range
- $36.00 – $73.44
- Volume
- 3.85M
- Avg. volume
- 2.76M
Price performance · EXEL
EXEL price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
EXEL closed at $72.31 after 20 trading sessions, up 23.73% for the selected period.
- Last close
- $72.31
- Period change
- +23.73%
- Period low
- $58.44
- Period high
- $72.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $70.11 | $73.44 | $70.11 | $72.31 | 3.85M |
| Nov 2, 2026 | $69.525 | $72.01 | $69.15 | $70.13 | 5.59M |
| Oct 30, 2026 | $68.28 | $72.10 | $67.05 | $69.39 | 5.07M |
| Oct 29, 2026 | $66.93 | $67.5199 | $65.06 | $66.20 | 2.84M |
| Oct 28, 2026 | $64.90 | $66.38 | $64.75 | $66.28 | 1.64M |
| Oct 27, 2026 | $64.70 | $65.48 | $64.385 | $65.35 | 1.43M |
| Oct 26, 2026 | $64.85 | $65.585 | $64.57 | $65.11 | 1.67M |
| Oct 23, 2026 | $65.15 | $65.20 | $63.91 | $64.53 | 2.07M |
| Oct 22, 2026 | $64.74 | $65.50 | $64.33 | $65.31 | 1.71M |
| Oct 21, 2026 | $64.12 | $64.7836 | $64.11 | $64.58 | 1.49M |
| Oct 20, 2026 | $63.01 | $64.42 | $62.845 | $64.39 | 2.14M |
| Oct 19, 2026 | $61.84 | $62.81 | $61.67 | $62.68 | 1.93M |
| Oct 16, 2026 | $62.98 | $63.39 | $61.74 | $62.23 | 2.64M |
| Oct 15, 2026 | $61.69 | $63.31 | $61.2801 | $62.83 | 2.77M |
| Oct 14, 2026 | $59.92 | $61.175 | $59.56 | $60.99 | 2.75M |
| Oct 13, 2026 | $60.00 | $60.00 | $58.59 | $59.51 | 2.62M |
| Oct 12, 2026 | $60.48 | $61.66 | $59.80 | $59.82 | 3.13M |
| Oct 9, 2026 | $59.00 | $60.83 | $59.00 | $59.86 | 2.67M |
| Oct 8, 2026 | $58.07 | $60.08 | $57.91 | $59.02 | 2.68M |
| Oct 7, 2026 | $58.47 | $59.265 | $57.88 | $58.44 | 2.37M |
Latest EXEL news
The latest Smart Investors Daily articles mentioning EXEL.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

